Chemoinformaics analysis of (2S)-4-[(E)-2-(CARBOXYMETHYLAMINO)VINYL]-2,3-DIHYDROPYRIDINE-2,6-DICARBOXYLIC ACID
| Molecular Weight | 268.225 | nRot | 5 |
| Heavy Atom Molecular Weight | 256.129 | nRig | 9 |
| Exact Molecular Weight | 268.07 | nRing | 1 |
| Solubility: LogS | -1.341 | nHRing | 1 |
| Solubility: LogP | -0.384 | No. of Aliphatic Rings | 1 |
| Acid Count | 3 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 33.3835 |
| nHD | 4 | BPOL | 16.3525 |
| QED | 0.401 |
| Synth | 3.298 |
| Natural Product Likeliness | 0.478 |
| NR-PPAR-gamma | 0.029 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.121 |
| HIA | 0.348 |
| CACO-2 | -6.02 |
| MDCK | 0.00036942 |
| BBB | 0.143 |
| PPB | 0.434705 |
| VDSS | 0.352 |
| FU | 0.601421 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.033 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.038 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.134 |
| CYP2d6-inh | 0.036 |
| CYP2d6-sub | 0.109 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.008 |
| CL | 1.826 |
| T12 | 0.905 |
| hERG | 0.019 |
| Ames | 0.008 |
| ROA | 0.002 |
| SkinSen | 0.089 |
| Carcinogencity | 0.018 |
| EI | 0.162 |
| Respiratory | 0.914 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.516178 |